The Scalp Care Collection runs on 1.8 percent salicylic acid or 1 percent zinc pyrithione. In the US both are drug actives. In the EU one is banned.

China eased cosmetics registration and customs for importers through 2026 while French shipments reportedly slowed. The lever is discretionary.

A new EU rule caps PFHxA at 25 ppb in cosmetics from 10 October 2026. It tests the finished product and never asks if the chemical was added on purpose.

This article analyzes South Korea's new interagency council, launched October 2, 2026, to combat counterfeit K-beauty products abroad. While Korean customs effectively seizes fakes at its own border (41,903 cosmetic items in 2025), government agencies lack enforcement power over overseas platforms like Amazon and TikTok Shop. The response highlights that trademark registration in foreign markets remains the only proactive defense for brands.

South Korea licenses 11 functional cosmetic claim categories, like wrinkle care or UV protection. In contrast, the US FDA pre-approves no cosmetics. Under US law, functional claims alter a product's intended use—reclassifying a cosmetic as an unapproved drug. While MoCRA increases US facility listings, domestic Korean claims on exported goods still cause import detentions and refusals.

Comments on two Korean cosmetics notices closed on 18 September 2026, and the coverage has been about price: an SPF test that takes about a month and costs about six million won drops to about two days and about 3.5 million. Buried in the same package is the clause that moves more money. It narrows the waiver that lets a second, third and twelfth brand ride an already-approved sunscreen dossier without running a test at all. The test gets cheaper. The number of products that

Korea gates commercial cosmetics imports through a registrant. An importer registers as a responsible distributor under Article 3 of the Cosmetics Act, files a clearance report before customs release, and tests each batch before sale. On 17 September two agencies announced that roughly 97,000 counterfeit units had moved through Coupang and Naver over fourteen months. None of those controls failed. None of them applied.

Korea founded the Global Cosmetics Regulatory Authority Summit (GCORAS) to lead regulatory alignment across key export markets like ASEAN, the Middle East, and Latin America. Paired with Korea’s mandatory Safety Assessment regime phasing in from 2028, GCORAS aims to establish mutual recognition for safety dossiers. This turns a domestic compliance burden into a portable global export asset, mitigating fixed compliance costs for indie brands while expanding ODM service roles.

K-Beauty clinical trials have devolved into a profit-driven circus where testing labs unbundle basic device metrics to inflate fees, while subject recycling and data manipulation threaten scientific validity. Domestic brands overspend on superficial device scores, whereas fast-growing brands opt for cost-effective user surveys. Overseas, lax clinical data poses catastrophic legal risks under post-market compliance systems like MoCRA (US) and CPNP (Europe).

Canada applies counter-tariffs to a list of American goods from 8 September 2026, and in cosmetics the list names exactly five tariff lines, all at 50%: perfume, lip make-up, eye make-up, manicure and pedicure preparations, and the residual hair line. Face and skin care preparations are not on it. Neither is shampoo. That single fact reverses the reading now circulating in the Korean trade press, because the categories the measure opens are not the categories Korean brands se

Indonesia’s transition period for mandatory halal cosmetic certification ends October 17, 2026, with enforcement starting October 18 under Government Regulation No. 42 of 2024. The rule applies equally to local and foreign brands. Compliance requires factory changes—separating lines, tracking ingredients, and appointing a supervisor. However, foreign exporters face heavy administrative friction: brands must file through local importers.

Nothing in an American refusal notice for a Korean cosmetic is about chemistry. In FY2025, 69 per cent of Korea's US FDA cosmetics import refusals came down to labelling, and the same month that Korea's own regulator published its August enforcement record, five of its nine actions were for advertising liable to be mistaken for medicine. The compliance failure that actually stops Korean cosmetics, in both jurisdictions, is the sentence on the label — not the formula in the ja

Korea's National Assembly passed the Act on the Fostering and Support of the Cosmetics Industry on 20 August 2026. The only genuinely new instrument in it — certification as an "innovative cosmetics company" — has its qualifying thresholds left entirely to presidential decree. That means the law that decides who benefits will be written over the next twelve months, not last week, and if it is written as an R&D-spending gate it will certify the manufacturers and miss the expor

The Korean Intellectual Property Office is registering a K-Brand certification mark in 70 export countries and holding the rights itself. That choice of legal instrument is the argument: a certification mark exists precisely because the thing being protected belongs to a whole class of producers rather than to any one of them. This piece sets out why "K-beauty" is a country-of-origin commons rather than brand equity, and what a Korean exporter actually owns once the adjective

Saudi Arabia's FDA will prohibit cosmetic products in syringe form starting 1 January 2027. Ampoules and vials remain permitted conditionally if they feature four specific Arabic and English warnings on packaging. Brands have until 31 December 2026 to recall affected stock and update compliance. This regulation treats packaging format as an implied claim, requiring K-beauty brands to audit both bilingual labelling and marketing assets to avoid market restrictions.

Korean cosmetics exports to Brazil surged 86.4% in the first half of 2026, yet demand is not the true driver of success. The real bottleneck is regulatory compliance: every cosmetic must be registered with ANVISA, with sunscreen dossiers taking six to twelve months. While recent bilateral agreements and presidential visits signal future regulatory reliance and trade alignment, navigating these strict approval processes remains the decisive factor for Korean brands entering th

Foreign brands are increasingly marketing themselves as K-beauty, and the Korean cosmetics industry is reading this as dilution of a national asset. It is not dilution. "K-beauty" was never a protected designation, never had a certification scheme, and was never enforceable — and the reason foreign brands can now borrow it freely is that Korean firms spent fifteen years building a category rather than defensible individual brands.

The US Trade Representative's Section 301 forced-labor tariffs, finalized on 23 July 2026, tie a country's rate directly to whether its economy formally prohibits imports made with forced labor. South Korea was placed in the 12.5% band rather than the 10% tier. For a cosmetics sector that now sends 20.7% of its exports to the US, this transforms raw-material supply chain documentation from routine corporate responsibility into a major tariff variable.

The FDA’s historic approval of bemotrizinol (BEMT) marks the first new sunscreen ingredient in the U.S. since 1999. While this adds a game-changing UV filter to the market, it presents complex regulatory hurdles under MoCRA for global brands. Discover the strategic formulation, supply chain, and compliance shifts required for K-Beauty to legally scale in the U.S. sun care sector.